enclomiphene citrate

DRUG3 trials

Sponsors

Repros Therapeutics Inc., Baylor College of Medicine

Conditions

Effect of Treatment on Bone Mineral DensityInfertilitySecondary Hypogonadism

Phase 2

Androxal in Male Infertility

WithdrawnNCT02160704

Baylor College of MedicineInfertility

Start: 2014-09-22End: 2016-08-02Updated: 2019-07-11

Phase 3

Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism

CompletedNCT01619683

Repros Therapeutics Inc.Effect of Treatment on Bone Mineral Density

Start: 2012-09-30End: 2014-09-30Updated: 2014-10-01

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

CompletedNCT01739595

Repros Therapeutics Inc.Secondary Hypogonadism

Start: 2012-11-30End: 2013-09-30Updated: 2015-05-27